False-positive results – and incorrect treatment – can occur when specific mutations, unrelated to cancer, are present in blood plasma.
Researchers looked at data from 11,003 patients in 135 primary-care clinics in nine states using the collaborative-care model.
He led the hospital's efforts toward equity, diversity and inclusion, as well as an innovative peace project to counter racial tensions.
Preclinical data published in Cell show the nanoparticle vaccine spurs extremely high levels of protective antibodies in animal models.
Research program analyzes cerebrospinal fluid molecules to seek diagnostic and progression markers as well as treatment targets.
Results in Open Forum Infectious Diseases show hydroxychloroquine does not protect people from the novel coronavirus.
The latest analysis by Institute of Health Metrics and Sciences suggests a perfect storm of aggravating factors.
Changes observed in the nuclei of cells emerging in mouse embryos will chart genomics of mammalian development.
Teams in Seattle and Cleveland are pursuing an experiment to regenerate crucial cells and create a new therapy model.
UW Medicine, Fred Hutch scientists will jointly test whether the monoclonal drug can prevent infection among people exposed to COVID-19.